Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Electronic Gene Ontology annotations created by ARBA machine learning models
Functional interactions between the ciliopathy-associated Meckel syndrome 1 (MKS1) protein and two novel MKS1-related (MKSR) proteins.
A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain.
-
B9D1, TMEM231 and CC2D2A localizations at the transition zone are interdependent. Disrupting their complex alters ciliary membrane composition and diffusion, linking the assembly to a ciliary compartment barrier.
A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.
An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.
Formation of the B9-domain protein complex MKS1-B9D2-B9D1 is essential as a diffusion barrier for ciliary membrane proteins.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Multimodal cell maps as a foundation for structural and functional genomics.
RAB3IP stimulates nucleotide exchange on RAB8A
Recruitment of transition zone proteins
CEP164 recruits RAB3IP-carrying Golgi-derived vesicles to the basal body
Publisher Correction: Multimodal cell maps as a foundation for structural and functional genomics.
Disruption of a ciliary B9 protein complex causes Meckel syndrome.
Ciliopathy-related B9 protein complex regulates ciliary axonemal microtubule posttranslational modifications and initiation of ciliogenesis.
-
Human B9D1-knockout RPE1 cells have impaired ciliogenesis and CP110 removal, with reduced axonemal tubulin acetylation and polyglutamylation but unchanged whole-cell tubulin modifications. Detailed enzyme-trafficking and vesicle assays predominantly concern B9D2 or TMEM67; patient variants concern B9D2.